OS

Oliver Schoor

IG Immatics Biotechnologies Gmbh: 92 patents #3 of 48Top 7%
📍 Rötteln, DE: #3 of 26 inventorsTop 15%
Overall (2021): #67 of 548,734Top 1%
92
Patents 2021

Issued Patents 2021

Showing 26–50 of 92 patents

Patent #TitleCo-InventorsDate
11065314 Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers Andrea Mahr, Toni Weinschenk, Helen Hoerzer, Jens Fritsche, Harpreet Singh 2021-07-20
11065316 Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2021-07-20
11065315 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Phillip Mueller +2 more 2021-07-20
11065279 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-07-20
11058727 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-07-13
11058755 A*03 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Linus Backert, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche +2 more 2021-07-13
11058754 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Phillip Mueller +2 more 2021-07-13
11058726 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Anita Wiebe, Colette Song, Jens Fritsche +1 more 2021-07-13
11052113 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-07-06
11052114 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-07-06
11040069 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-22
11033585 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-15
11033583 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-15
11027002 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-06-08
11026977 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-08
11020434 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-01
11020433 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-01
11013766 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-05-25
11013768 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-05-25
11013769 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-05-25
11014972 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-05-25
11007258 Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Toni Weinschenk, Jens Fritsche, Harpreet Singh, Andrea Mahr, Martina Ott +1 more 2021-05-18
11007257 Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Toni Weinschenk, Jens Fritsche, Harpreet Singh, Andrea Mahr, Martina Ott +1 more 2021-05-18
11001617 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +2 more 2021-05-11
11001616 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Colette Song, Jens Fritsche, Toni Weinschenk, Harpreet Singh 2021-05-11